Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boston Scientific(MODEST), Janssen Scientific Affairs(MODEST), Cine-Med Research Institute(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Applied Therapeutics(SIGNIFICANT), Caret, bought by Boston Scientific(SIGNIFICANT), STEL(SIGNIFICANT), CONTROLRAD(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), DSI(SIGNIFICANT), Medtronic(SIGNIFICANT), OrbusNeich(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Concept Medical(SIGNIFICANT), Chiesi(SIGNIFICANT), CERC(SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Elixir Medical(MODEST)

View Full Disclosure